This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
As the field of life sciences continues to advance, the demand for high-quality, specialized in vitro consumables has surged. Researchers rely on these tools to ensure the reliability and reproducibility of their results, ultimately contributing to the development of new therapies, diagnostic methods, and a deeper understanding of biological phenomena. Consumables for several clinical areas, such as infectious disease, oncology/cancer, cardiology, HIV/AIDS, and nephrology have seen rapid growth. Additionally, recent infectious disease outbreaks, such as COVID-19, have further propelled the growth of the global market.
The exponential rise in the application of precision medicine on the global level has created a buzz among companies to invest in the development of IVD to increase the accuracy and to ensure shorter turn-around time for disease diagnosis. Due to the diverse product portfolio and intense market penetration, F. Hoffmann-La Roche has been a pioneer in this field and has been a significant competitor in this market.
This dynamic market includes a wide array of in-vitro consumables, including reagents and assays, test kits and other consumables. This dynamic market continually evolves to meet the growing demands of researchers, ensuring a robust foundation for scientific exploration.
The report delves into various factors influencing the industry, including recent trends, recent advancements, and regulatory aspects. It outlines the market segmentation based on product type, end-user and region.
Geographically, North America is poised to emerge as a major contributor to the growth of the in vitro consumables market due to several factors. The region boasts a well-established infrastructure for research and development, with a concentration of leading pharmaceutical, biotechnology, and diagnostic companies. Additionally, the presence of advanced healthcare facilities and a strong emphasis on technological innovation fosters the demand for cutting-edge in vitro consumables.
Market Segmentation:
Segmentation by Product Type
- Reagents
- Test Kits
- Other Consumables
Segmentation by End User
- Hospitals
- Diagnostic Centers
- Research
- Others
Segmentation by Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Rest-of-the-World
Key Questions Answered:
- What are the major market drivers, challenges and opportunities in the global In-Vitro diagnostics consumables market and their case studies?
- How the in-vitro diagnostics consumables market evolve and what did is its scope in the future?
- What is the market share of the leading segments and sub-segments of the global in-vitro diagnostics consumables market?
- How will each segment of the global in-vitro diagnostics consumables market grow during the forecast period?
- What are the influencing factors that may affect the market share of the key players?
- How will the industry evolve during the forecast period between 2023 and 2033?
- What are the key developmental strategies implemented by the key players to stand out in this market?
Table of Contents
Companies Mentioned
- F. Hoffmann-La Roche Ltd
- Siemens Healthineers
- Abbott Laboratories, Inc.
- Thermo Fisher Scientific
- Quest Diagnostics Incorporated
- Bio-Rad Laboratories, Inc
- Becton, Dickinson and Company
- Sysmex Corporation
- QuidelOrtho Corporation
- DiaSorin S.p.A
- Biomérieux SA
- Hologic, Inc.
- Laboratory Corporation of America Holdings
- Danaher Corporation
- Illumina, Inc.
